Correlation Between Eliem Therapeutics and Panbela Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Panbela Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Panbela Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Panbela Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Panbela Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Panbela Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Panbela Therapeutics.

Diversification Opportunities for Eliem Therapeutics and Panbela Therapeutics

0.84
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Eliem and Panbela is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Panbela Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Panbela Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Panbela Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Panbela Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Panbela Therapeutics go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Panbela Therapeutics

If you would invest  206.00  in Panbela Therapeutics on August 28, 2024 and sell it today you would earn a total of  0.00  from holding Panbela Therapeutics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy1.61%
ValuesDaily Returns

Eliem Therapeutics  vs.  Panbela Therapeutics

 Performance 
       Timeline  
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Panbela Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Panbela Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong essential indicators, Panbela Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Eliem Therapeutics and Panbela Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eliem Therapeutics and Panbela Therapeutics

The main advantage of trading using opposite Eliem Therapeutics and Panbela Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Panbela Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Panbela Therapeutics will offset losses from the drop in Panbela Therapeutics' long position.
The idea behind Eliem Therapeutics and Panbela Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Content Syndication
Quickly integrate customizable finance content to your own investment portal